Previous close | 8.22 |
Open | 8.25 |
Bid | 8.29 x 1000 |
Ask | 8.32 x 1600 |
Day's range | 8.11 - 8.32 |
52-week range | 7.53 - 15.70 |
Volume | |
Avg. volume | 4,584,481 |
Market cap | 1.319B |
Beta (5Y monthly) | 0.55 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Ironwood (IRWD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
OPKO Health (OPK) and Entera Bio announce robust pharmacokinetic results for the proprietary GLP-2 agonist developed by OPK Heath.
Shares of Ironwood Pharmaceuticals collapsed Thursday on mixed results for its gastrointestinal drug. The biotech stock erased a 38% gain.